Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

VTB to buy fractional shares from minority shareholders

7/5/24 VTBR

InterRAO to compete for ₽54 billion project

7/5/24 IRAO

VTB plans to buy Russian Post's stake in Pochta Bank

7/5/24 VTBR

IPO VseInstrumenty passed on the lower boundary

7/5/24 VSEH

Shareholders of Element approved dividends for 2023

7/4/24 ELMT

Shareholders of United Heavy Machinery approved dividends for 2023

7/4/24 OMZZP

Shareholders of Novorossiysk Commercial Sea Port approved dividends for 2023

7/4/24 NMTP

Samolet is thinking about the IPO of the IT part of the business

7/4/24 SMLT

Samolet is working on the economic efficiency of sites in the Moscow region

7/4/24 SMLT

OGK-2 increased electricity generation by 16.2% in the 1st half of the year

7/4/24 OGKB